EXPERT EXCHANGE: Advances in Biomarker-Driven Immune Checkpoint Blockade for Selected Types of Solid Tumors

Immune checkpoint inhibition (ICI) targeting cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and programmed cell death 1 pathway (PD-1/PD-L1) has dramatically improved the care of patients with many advanced malignancies.1...

 Read More

Updates in Antiepileptic Therapy: Evaluating New Agents and Recent Evidence to Aid in the Selection of Treatment

Epilepsy is a spectrum of multiple neurologic disorders which are complex in diagnosis, management, and all phases of care.1 An estimated 2.9 million Americans are affected by epilepsy, and 1 in 26 people in the US will develop...

 Read More

Multiple Presenters Randa Jarrar; David Spencer;

CEC oncology is live. Visit our new site today.

 Read More